- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/49 - Cinchonan derivatives, e.g. quinine
Patent holdings for IPC class A61K 31/49
Total number of patents in this class: 141
10-year publication summary
|
8
|
13
|
14
|
15
|
15
|
17
|
14
|
12
|
13
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Avanir Pharmaceuticals, Inc. | 32 |
10 |
| The Regents of the University of California | 19929 |
6 |
| Concert Pharmaceuticals, Inc. | 247 |
6 |
| Beijing Showby Pharmaceutical Co., Ltd. | 15 |
4 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10912 |
3 |
| Mindlab LLC | 5 |
3 |
| Mutual Pharmaceutical Company, Inc. | 25 |
3 |
| Pharma Mar, S.A. | 211 |
3 |
| Immunologik GmbH | 12 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 761 |
2 |
| The Trustees of the University of Pennsylvania | 4323 |
2 |
| Arena Pharmaceuticals, Inc. | 366 |
2 |
| General Mills, Inc. | 993 |
2 |
| Indiana University Research and Technology Corporation | 799 |
2 |
| MetrioPharm AG | 48 |
2 |
| Neurocrine Biosciences, Inc. | 422 |
2 |
| NeuroDerm, Ltd. | 137 |
2 |
| New York Blood Center, Inc. | 164 |
2 |
| Orion Corporation | 648 |
2 |
| Sumitomo Dainippon Pharma Co., Ltd. | 216 |
2 |
| Other owners | 78 |